FDA Inspections To Focus On Sterile Rx, New Facilities In FY 2003
Executive Summary
FDA will continue to emphasize inspection of sterile manufacturing facilities in fiscal year 2003, Division of Manufacturing & Product Quality Director Joseph Famulare said Dec. 11